Advertisement

Veränderungen im Knochenstoffwechsel und/oder an der Knochenmatrix

  • J. Freyschmidt

Zusammenfassung

Die Komplexität des Knochenstoffwechsels impliziert zwangsläufig die verschiedensten Störungen, deren Spektrum von der systemischen Osteoporose über den primären und sekundären Hyperparathyreoidismus, den Hypoparathyreoidismus, die Osteomalazie, die renale Ostepathie bis zu toxischen und durch Pharmaka ausgelösten Skelettveränderungen reicht. Dieses Kapitel gehört sicherlich zu den interessantesten innerhalb der Skelettradiologie.

Literatur

  1. Abreu de MR, Wessely M, Chung CB, Resnik D (2011) Bone marrow imaging findings in disuse osteoporosis. Skeletal Radiol 40:57–1CrossRefGoogle Scholar
  2. Adams JE (2009) Quantitative computed tomography. Eur J Radiol 71:41–5CrossRefGoogle Scholar
  3. Albright F, Burnett CH, Smith PH et al (1942) Pseudohypoparathyroidism. An example of »seabrightBantam-syndrome«. Report of three cases. Endocrinology 30:92–2Google Scholar
  4. Anderson DE, Davidson JK, Catto ME (1983) Primary hyperoxaluria. Case report 227. Skeletal Radiol 9:26–6CrossRefGoogle Scholar
  5. Andresen J, Nielsen HE (1980) Renal osteodystrophy in nondialysed patients with chronic renal failure. Acta Radiol Diagn 21:80–3Google Scholar
  6. Andresen R, Radmer S, Banzer D et al (1994) Quantitative Knochenmineralgehaltsbestimmung (QCT). Systemvergleich baugleicher Computertomographen. RÖFO 160:26–0Google Scholar
  7. Ansell G, Evans S, Jackson CT (1983) Cytotoxic drugs for nonneoplastic disease. Br Med J 287:76–2CrossRefGoogle Scholar
  8. Aunsholt NA, Biskjoer NL (1989) Tumoral calcification in association with renal osteodystrophy. RÖFO 151:23–7Google Scholar
  9. Bamias A (2006) Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 23:858–0Google Scholar
  10. Bardin T, ZingraffJ, Shirahama T (1987) Hemodialysisassociated amyloidosis and Beta-2 microglobulin: clinical and immunohistochemical study. Am J Med 83:41–9CrossRefGoogle Scholar
  11. Baron R, Hesse E (2012) Update on bone anabolics in osteoporosis treatment: Rationale, current status, and perspectives. J Clin Endocrinol Mertab 97:31–1Google Scholar
  12. Bartl R, Bartl C, Gradinger R (2010) Medikamenteninduzierte Osteopathien. Z Rheumatol 69:13–5Google Scholar
  13. Benkert A, Tschammler A, Bahner U et al (1994) Verlaufsbeurteilung einer tumorösen Kalzinose vor und nach Parathyreoidektomie bei sekundärem Hyperparathyreoidismus. RÖFO 161:9–0Google Scholar
  14. Berthold LD, Haras G, Mann M et al (2006) Trabekuläre Knochendichte der Lendenwirbelsäule bei Kindern und Jugendlichen in der quantitativen CT: Referenzwerte und Peak Bone Mass. Fortschr Röntgenstr 178:123–5Google Scholar
  15. Berthold LD, Moritz JD, Soenksen S et al (2006) Messung der Knochendichte bei Kindern und Jugendlichen mittels quantitativer CT an nur einem Lendenwirbelkörper. Fortschr Röntgenstr 178:29–2Google Scholar
  16. Bhate DV, Supan WA, Sparagana M et al (1979) Paget disease and primary hyperparathyroidism. Case report 94. Skeletal Radiol 4:11–5CrossRefGoogle Scholar
  17. Biggemann M, Hilweg D, Brinckmann P (1989) Experimentelle Untersuchungen zur quantitativen computertomographischen Vorhersage der Kompressionsfestigkeit thorakolumbaler Wirbelkörper. RÖFO 151:32–2Google Scholar
  18. Black DM, Cummings SR, Stone K et al (1991) A new approach to defining normal vertebral dimensions. J Bone Miner Res 6:88–3Google Scholar
  19. Block GA, Hulbert-Shearon TE, Levin NW et al (1998) Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31:60–7CrossRefGoogle Scholar
  20. Boillat MA, Garcia J, Velebit L (1980) Radiological criteria of industrial fluorosis. Skeletal Radiol 5:16–1CrossRefGoogle Scholar
  21. Bone HG, Hosking D, Devogelaer JP (2004) Ten years‘ experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350:1–2CrossRefGoogle Scholar
  22. Borders J, Kerr E, Sartoris DJ et al (1989) Quantitative dual-energy radiographic absorptiometry of the lumbar spine: in vivo comparison with dual-photonabsorptiometry. Radiology 170:12–9CrossRefGoogle Scholar
  23. Brecht G, Schweikert HU (1982) Röntgenbefunde beim Pseudohypoparathyreoidismus. RÖFO 136:73–7Google Scholar
  24. Burnstein MJ, Kottamasu SR, Pettifor JM et al (1985) Metabolic bone disease in pseudohypoparathyroidism: radiologic features. Radiology 155:35–1CrossRefGoogle Scholar
  25. Byers PD, Stamp TCB, Stoker DJ (1985) Fibrogenesis imperfecta ossium (FIO). Case report 296. Skeletal Radiol 13:7–2CrossRefGoogle Scholar
  26. Chanard J, Lavaud S, Toupange D et al (1986) Beta-2-microglobulin associated amyloidosis in chronic hemodialysis patients. Lancet 1:121–2Google Scholar
  27. Chen H, Han Y, Li X, Liu X, Feng W, Xu W (2013) Hypophosphatasia. Skeletal Radiol 42:295,31–7Google Scholar
  28. Christ F et al (1982) Primäre Oxalose im Jugendalter. RÖFO 136:17–4Google Scholar
  29. Christiansen C, Christensen MS, McNair P et al (1980) Prevention of early postmenopausal bone loss; controlled 2-year study in 314 normal females. Eur J Clin Invest 10:27–3CrossRefGoogle Scholar
  30. Christiansen C, Christensen MS, Transbre J (1981) Bone mass in postmenopausal woman after withdrawal of estrogen/gestagen replacement therapy. Lancet I:459Google Scholar
  31. Christiansen C, Christensen MS, Largus NE et al (1982) Pathophysiological mechanism of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women. J Clin Endocrinol Metab 55:112–4CrossRefGoogle Scholar
  32. Christie DP (1980) The spectrum of radiographic bone changes in children with fluorosis. Radiology 136:8–5CrossRefGoogle Scholar
  33. Coral AM, van Holsbeeck M, Hegg C (1990) Secondary oxalosis complicating chronic renal failure (Case report). Skeletal Radiol 19:14–7CrossRefGoogle Scholar
  34. Costello JM, Dent CE (1963) Hypohyperparathyroidism. Arch Dis Child 38:39–7CrossRefGoogle Scholar
  35. Coursey C, Weber T, Dodd L et al (2007) Fibrogenesis imperfecta ossium: MR imaging of the axial and appendicular skeleton and correlation with a unique radiographic appearance. Skeletal Radiol 36:107–7CrossRefGoogle Scholar
  36. Cranney A, Guyatt G, Griffith L (2002) Übersicht über Metanalysen von Therapien der postmenopausalen Osteoporose. Endocr Rev 23:5Google Scholar
  37. Därr R, Ziller V, Hadji P et al (2008) Klinik und Diagnostik der Osteoporose und Osteomalazie. Internist 49:117–0CrossRefGoogle Scholar
  38. Dalén N, Furukjehn M, Jacobson B (1978) Changes in bone mineral content in women with natural menopause during treatment with female sex hormones. Acta Obstet Gynaecol Scand 57:43–5CrossRefGoogle Scholar
  39. Dalén N, Hellström LG, Jacobson B (1976) Bone mineral content and mechanical strength of the femoral neck. Acta Orthop Scand 47:50–3Google Scholar
  40. De Carvalho A, Jurik AG, Illum F (1986) Idiopathic hypoparathyroidism (Case report 335), Skeletal Radiol 15:5–2CrossRefGoogle Scholar
  41. De Smet AA, Robinson, Johnson BE et al (1988) Spinal compression fractures in osteoporotic women: patterns and relationship to hyperkyphosis. Radiology 166:49–7CrossRefGoogle Scholar
  42. Dellaudière B, Lincot L, Cotten A et al (2013) Unusual facial enlargement. Skeletal Radiol 42:86–9Google Scholar
  43. Delling G (1989a) Morphologie endokriner Osteopathien. In: Hesch RD Endokrinologie, Teil A. Urban und Schwarzenberg, München (Innere Medizin der Gegenwart, Bd 4, S 526-536)Google Scholar
  44. Delling G (1989b) Osteopathie bei primärem Hyperparathyreoidismus. In: Hesch RD Endokrinologie, Teil A. Urban & Schwarzenberg, München (Innere Medizin der Gegenwart Bd 4, S 529)Google Scholar
  45. Delling G (1989c) Renale Osteopathie. In: Endokrinologie, Teil A. Urban & Schwarzenberg, München (Innere Medizin der Gegenwart Bd 4, S 19)Google Scholar
  46. Delmas PD, Bjanarson NH, Mitlak BH et a. (1997) Effects of raloxyfene on bone mineral density, serum cholesterol concentrations and uterine endometrium in postmenopausal women. N Engl J Med 337:64–1CrossRefGoogle Scholar
  47. Dent CE, Richens A, Rowe DJF et al (1970) Osteomalacia with long-term anticonvulsant therapy in epilepsy. Br Med J 4:6–9CrossRefGoogle Scholar
  48. Dillman RO, Crumb CK, Lidsky MJ (1979) Lead poisoning from a gunshot wound: report of a case and review of the literature. Am J Med 66:50–9CrossRefGoogle Scholar
  49. Doyle FH (1966) Some quantitative radioIogical observations in primary and secondary hyperparathyroidism. Br J Radiol 39:16–1Google Scholar
  50. Ecklund K, Laor T, Goorin AM et al (1997) Methotrexate osteopathy in patients with osteosarcoma. Radiology 202:54–3CrossRefGoogle Scholar
  51. Epstein DM, Dalinka MK, Kaplan FS et al (1986) Observer variation in the detection of osteopenia. Skeletal Radiol 15:34–7CrossRefGoogle Scholar
  52. Fernandes JL, Rocha AAL, Soares MVA et al (2007) Lead arthropathy: radiographic, CT, MRI findings. Skeletal Radiol 36:64–7CrossRefGoogle Scholar
  53. Fernandes JL, Viana SL, Rocha AL et al (2004) Bisphosphonate-induced radiographic changes in two pediatric patients with rheumatic diseases. Skeletal Radiol 33:73–2CrossRefGoogle Scholar
  54. Fink B, Rüther W, Busch T et al (1993) Multiple aseptische Knochennekrosen bei chronischer Hämodialyse. Osteologie 2:22–8Google Scholar
  55. Firooznia H, Golimbu C, Rafii M (1985) Progressive paraparesis in a woman with pseudohypoparathyroidism with ossification of posterior longitudinal ligament from C4 to C5. Skeletal Radiol 13:31–0CrossRefGoogle Scholar
  56. Firooznia H, Golimbu C, Rafii M et al (1986) Rate of spinal trabecular bone loss in normal perimenopausal women: CT measurements. Radiology 161:73–5CrossRefGoogle Scholar
  57. Frame B, Guiany HL, Frost HM et al (1971) Osteomalacia induced by laxative (Phenolphythalein) ingestion. Arch Intern Med 128:79–4CrossRefGoogle Scholar
  58. Funke M, Bruhn H, Vosshenrich R et al (1994) Bestimmung der T2*-Relaxationszeit zur Charakterisierung des trabekulären Knochens. RÖFO 161:5–8Google Scholar
  59. Gagliardi JA, Evans EM, Chandnani VP et al (1995) Osteogenesis imperfecta complicated by osteosarcoma. Skeletal Radiol 24:30–8CrossRefGoogle Scholar
  60. Garrett P, McWade M, O‘Callahan J (1986) Radiological assessment of aluminium-related bone disease. Clin Radiol 37:7–3CrossRefGoogle Scholar
  61. Genant HK, Baron JM, Straus FH II et aI. (1975) Osteosclerosis in primary hyperparathyroidism. Am J Med 59:10–4CrossRefGoogle Scholar
  62. Genant HK, Block JE, Steiger P et al (1989) Appropriate use of bone densitometry. Radiology 170:81–7CrossRefGoogle Scholar
  63. Genant HK, Wu CY, van Kujik C et al (1993) Vertebral fracture assessment using a semi-quantitative technique. J Bone Miner Res 8:113–7CrossRefGoogle Scholar
  64. Geusens P, Dequeker J, Vertraeten A et al (1986) Age-, sex- and menopause-related changes of vertebral and peripheral bone: population study using dual and single photon absorptiometry and radiogrammetry. J Nucl Med 27:154–0Google Scholar
  65. Gielen JL, van Holsbeeck MT, Hauglustaine D et al (1990) Growing bone cysts in long-term hemodialysis. Skeletal Radiol 19:4–3CrossRefGoogle Scholar
  66. Gilsanz V, Bernstein BH (1984) Joint calcification following intraarticular corticosteroid therapy. Radiology 151:64–7CrossRefGoogle Scholar
  67. Glüer CC, Steiger P, Selvidge R et al (1990) Comparative assessment of dual-photon-absorptiometry and dual-energy radiography. Radiology 174:22–3CrossRefGoogle Scholar
  68. Goh SK (2007) Subtrochanteric insufficiency fractures in patients on alendronate therapy. A caution. J Bone Joint Sury (Br) 89-B:34–9Google Scholar
  69. Golditz GA, Hankinson SE, Hunter DJ et al (1995) The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332:158–9Google Scholar
  70. Gordon GS (1977) Postmenopausal osteoporosis cause, prevention and treatment. Clin Obstet Gynaecol 4:16–9Google Scholar
  71. Griffin CN Jr (1982) Symmetrical ilial pseudofractures: a complication of chronic renal failure. Skeletal Radiol 8:29–5CrossRefGoogle Scholar
  72. Griffin CN Jr (1984) Severe erosive arthritis of large joints in chronic renal failure. Skeletal Radiol 12:2–9CrossRefGoogle Scholar
  73. Griffith GC, Nicols G Jr, Asher JD et al (1965) Heparin osteoporosis. JAMA 193:8–5CrossRefGoogle Scholar
  74. Hall FM, Segall-Blank M, Genant HK et aI. (1981) Pseudohypoparathyroidism presenting as renaI osteodystrophy. Skeletal Radiol 6:4–3Google Scholar
  75. Handly B, Moore M, Creutzberg G et al (2013) Bisphosphonate therapy for chronic recurrent multifocal osteomyelitis. Skeletal Radiol 42:177–7CrossRefGoogle Scholar
  76. Hardy DC, Murphy WA, Siegel BA et al (1989) X-linked hypophosphatemia in adults: prevalence of skeletal radiographic and scintigraphic features. Radiology 171:40–3CrossRefGoogle Scholar
  77. Harper PG, Trask C, Souham RL (1984) Avascular necrosis of bone caused by combination chemotherapy without cortico-steroids. Br Med J 288:26–7CrossRefGoogle Scholar
  78. Hasegawa T, Shimoda T, Yokoyama R et al (1999) Intracortical osteoblastic osteosarcoma with oncogenic rickets; Skeletal Radiol 28:4–1CrossRefGoogle Scholar
  79. Heath DA, Martin DJ (1970) Periosteal new bone formation in hyperparathyreoidism associated with renal failure. Br J Radiol 43:51–7CrossRefGoogle Scholar
  80. Hendersen ER, Jacobsen CM, Pohlmann RA (2013) Proximal tibial pain in a child. Skeletal Radiol 42:133–3Google Scholar
  81. Hesch RD (1989) Hyperparathyreoidismus. In: Hesch RD Endokrinologie, Teil B. Urban & Schwarzenberg, München (Innere Medizin der Gegenwart Bd 5, S 969)Google Scholar
  82. Hesch RD, Rittinghaus EF (1991) Abschließende Bewertung der Osteoporosetherapie mit Fluoriden. Internist 32:70–8Google Scholar
  83. Hochmuth K, Proschek D, Schwarz W et al (2006) Percutaneous vertebroplasty in the therapy of osteoporotic vertebral compression fractures: a critical review. Eur Radiol 16:99–8CrossRefGoogle Scholar
  84. Hodsman AB, Sherrard DJ, Wong EGC et al (1981) Vitamin D resistent osteomalacia in hemodialysis patients lacking secondary hyperparathyroidism. Ann Intern Med 94:62–9CrossRefGoogle Scholar
  85. Holick ME (2002) Vitamin D: The underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opinion Endocrinol Diabetes 8:8–7Google Scholar
  86. Hruska KA, Teitelbaum SL (1995) Renal osteodystrophy (Review article). N Engl J Med 333:16–6Google Scholar
  87. Huynh J, Obaid H (2015) Right thigh pain. Skeletal Radiol 44:76–3CrossRefGoogle Scholar
  88. IhIe BU, Becker GJ, Kincaid-Smith PS (1986) Clinical and biochemical features of aluminium-related bone disease. Kidney Int 18:8–0Google Scholar
  89. Interdisziplinäres, Konsensuspapier zu Vertebroplastie/Kyphoplastie, (2005) Fortschr Röntgenstr 177:1590Google Scholar
  90. Isaacs M, Bansal M, Flombaum CD et al (1992) Stress fracture of the hip secondary to renal osteodystrophy and erosion of ischium due to amyloid deposition. Case report 772. Skeletal Radiol 22:12–9Google Scholar
  91. Israel E, Banerjee TR, Fitzmauris GM et al (2001) Effect of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med 345:94–8CrossRefGoogle Scholar
  92. Issever AS, Link TM (2011) Radiologische Diagnostik der Osteoporose. Z Rheumatol 70:13–5Google Scholar
  93. Jacobson JA, Kalume-Brigida M (2006) Case 97: X-linked hypophosphatemic osteomalacia with insufficiency fracture. Radiology 240:60–7CrossRefGoogle Scholar
  94. Jakob F, Seefried L, Ebert R (2008) Pathophysiologie des Knochenstoffwechsels. Internist 49:115–9Google Scholar
  95. Janzen DL, Tirman PFJ, Rabassa AE et al (1995) Lead bursogram and focal synovitis secondary to retained intraarticular bullet fragment. Skeletal Radiol 24:14–2CrossRefGoogle Scholar
  96. Jehle PM (2003) Steroid-induced osteoporosis: how can it be avoided? Nephrol Dial Transplant 18:86–1CrossRefGoogle Scholar
  97. Jensen SP, Richardson ML, Conrad EU et al (1990) Retention of a bullet fragment within a traumatic pseudarthrosis, resulting in lead arthropathy and lead intoxication (case report 608). Skeletal Radiol 19:23–3Google Scholar
  98. Jergas M, San Valentin R (1995) Techniques for the assessment of vertebral dimentsions in qunatitative morphometry. In: Genant HK, Jergas M, van Kujik C Vertebral fractures in osteoporosis. Radiology Research and Education Foundation, San Francisco, pp 163–188Google Scholar
  99. Jonsson KB, Zahradnik R, Larsson T et al (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and x-linked hypophosphatemia. N Engl J Med 348:165–6CrossRefGoogle Scholar
  100. Kalender WA (1991) Abschätzung der effektiven Dosis bei Knochenmineralmessungen mit Photonenabsorptiometrie und Computertomographie. RÖFO 155:14–9Google Scholar
  101. Kalender WA, Brestowsky H, Felsenberg D (1988) Bone mineral measurement: automated determination of midvertebral CT section. Radiology 168:21–9CrossRefGoogle Scholar
  102. Kalender WA, Klotz E, Suess C (1987) Vertebral bone mineral analysis: an integrated approach with CT. Radiology 164:41–9Google Scholar
  103. Kalender WA, Perman WH, Vetter JR et al (1986) Evaluation of a prototype dual-energy computed tomographic apparatus. Med Phys 13:33–4CrossRefGoogle Scholar
  104. Kamphuis AGA, Geerlings W, Hazenberg BPC et al (1994) Annual evaduation of hip joints and hands for radiographic signs of ANM-amyloidosis in long-term hemodialysis patients. Skeletal Radiol 23:42–1CrossRefGoogle Scholar
  105. Kanis JA, Meunier PJ (1984) Should we use fluoride to treat osteoporosis? A review. QJ Med 210:14–5Google Scholar
  106. Kann PH, Hadji P, Bergmann RS (2014) Pharmakogene Osteoporose jenseits von Kortison. Z Rheumatol 73:32–3CrossRefGoogle Scholar
  107. Kaplan P, Resnick D, Murphy M et al (1987) Destructive noninfectious spondylarthropathy in hemodialysis patients. Radiology 162:24–1CrossRefGoogle Scholar
  108. Kasperczyk A, Freyschmidt J, Well JC et al (1991) Vergleichende Messung der Knochenmarksdosis bei der Quantitativen Computertomographie (QCT), Dual-Photonen-Radiographie (DPX) und konventionellen Röntgenaufnahme der LWS. RÖFO 155:15–5Google Scholar
  109. Ketteler M, Eckardt KU (2009) KDIG-Leitlinie zu den Störungen des Mineralund Knochenhaushalts bei chronischer Nierenerkrankung. Nephrologe 4:43–7Google Scholar
  110. Khairi MRA, Johnston CC (1977) Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP). Clin Orthop Res 127:9–4Google Scholar
  111. Kleerekoper M, Peterson E, Philips E et al (1989) Continuous sodium fluoride therapy does not reduce vertebral fracture rate in postmenopausal osteoporosis. J Bone Miner Res 4 [Suppl] 1:37–6Google Scholar
  112. Klotzbuecher CM, Ross PD, Landsmann PB et al (2000) Patients with prior fractures have an increased risk of future fractures: a summery of the literature and statistical synthesis. J Bone Miner Res 15:7211:10–3Google Scholar
  113. Kolb FO, Steinbach HL (1962) Pseudohypoparathyroidism with secondary hyperparathyroidism and osteitis fibrosa. J Clin Endocrinol Metab 22:5–9CrossRefGoogle Scholar
  114. Kopecki KK, Braunstein EM, Brandt KD et al (1991) Apparent avascular necrosis of the hip: appearance and spontaneous resolution of MR findings in renal allograft recipients. Radiology 179:52–3Google Scholar
  115. Koppers B, Schmid L, Hofmann E et al (1980) Chronische hypophosphatämische Osteopathie. RÖFO 133:3–4Google Scholar
  116. Krane SM (1982) Etidronate disodium in the treatment of Paget's disease of bone. Ann Intern Med 96:61–9CrossRefGoogle Scholar
  117. Krempien B, Manegold C (1992) Zur Indikation einer frühen Biphosphonat-Therapie bei Patienten mit soliden Tumoren. Dtsch Ärzteblatt 89 [B]:1414Google Scholar
  118. Kriegshauser JS, Swee RG, McCarthy JT et al (1987) Aluminium toxicity in patients undergoing dialysis: radiographic findings and prediction of bone biopsy results. Radiology 164:39–9CrossRefGoogle Scholar
  119. Kuhlencordt F, Kruse HP (1987) Malignant primary osteoporosis (Case report 422) Skeletal Radiol 16:40–7CrossRefGoogle Scholar
  120. Kuhlencordt J, Kruse HP, Franke J (1981) Diagnostischer Wert der Lamina dura alveolaris bei generalisierten Knochenerkrankungen. RÖFO 134:40–1Google Scholar
  121. Kuntz D, Naveau B, Bardin T et al (1984) Destructive spondylarthropathy in hemodialyzed patients. Arthritis Rheum 27:36–9CrossRefGoogle Scholar
  122. Kurland ES, Cosman F, McMahon DJ et al (2000) Parathyroid hormone at a therapy for idiopathic osteoporosis in men. J Clin Endocrin Metab 85:306–9Google Scholar
  123. Lachmann M, Kricun ME, Schwartz EE (1985) Primary hyperparathyroidism (HPR), with patchy diffuse osteosclerosis at multiple skeletal sites. Case report 310. Skeletal Radiol 13:24–8Google Scholar
  124. Lange U, Müller-Ladner U (2007) Glukokortikoid - induzierte Osteoporose. Z Rheumatol 66:12–9Google Scholar
  125. Lauritzen C (1990) Die Verhütung der Postmenopausen-Osteoporose durch Östrogen-Gestagen-Substitution. Dtsch Ärztebl 87:B–1419Google Scholar
  126. Lawson JP, McGuire J (1987) The spectrum of skeletal changes associated with long-term administration of 13-cis-retinoid acid. Skeletal Radiol 16:9–1CrossRefGoogle Scholar
  127. Le Stanc E, Wattel C, Hamey A (2009) FDG PET/CT findings in secondary hyperparathyroidism not mimicking multiple bone metastasis. Eur J Nucl Med Mol Imaging 36:33–4CrossRefGoogle Scholar
  128. Lehmann G, Wolf G (2014) Medikamentöse Therapie von Knochenstoffwechselstörungen bei CKD-MBD (chronic kidney disease-mineral bone disorder) unter besonderer Berücksichtigung antiresorptiver Wirkstoffe. Z Rheumatol 73:32–9CrossRefGoogle Scholar
  129. Lewis van L, Keats TE (1982) Bone end sclerosis in renal osteodystrophy simulating osteonecrosis. Skeletal Radiol 8:27–5Google Scholar
  130. Libicher M, Freyschmidt J (2006) Dialysis related amyloidomas presenting as bilateral gluteal mass. AJR 186:90–7CrossRefGoogle Scholar
  131. Link J, Zwaan M, Weiss H-D et al (1993) Erste Ergebnisse der lumbalen Zweienergie-Röntgenabsorptiometrie (DEXA) im Vergleich mit der Doppelencrgiequantitativen Computertomographie (DE-QCT). RÖFO 158:47–5Google Scholar
  132. Link TM, Koppers BB, Licht et al (2004) In vitro and vivo spiral CT to determine bone mineral density: initial experience in patients at risk for osteoporosis. Radiology 231:80–5Google Scholar
  133. Llewellyn CH, Resnik ChS, Brower AC (1984) Osteomalacia and secondary hyperparathyreoidism (dialysisinduced), with aluminium deposition. (case report 288) Skeletal Radiol 12:22–3CrossRefGoogle Scholar
  134. Manolagas SC (2000) Birth and death of bone cells: basic regulatory mechanism and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:11–5Google Scholar
  135. Manolagas SC, Jilka RL (1995) Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:30–5Google Scholar
  136. Manson JE, Hsia J, Johnson KC et al (2003) Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 349:52–3CrossRefGoogle Scholar
  137. Marcus R, Wang O, Satterwhite J et al (2003) The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoprosis. J Bone Miner Res 18:1–8CrossRefGoogle Scholar
  138. Mathis JM (2006) Percutaneous vertebroplasty or kyphoplasty: which one do I choose? Skeletal Radiol 35:62–9CrossRefGoogle Scholar
  139. Mautalen C, Vega E, Ghiringhelli G et al (1990) Bone diminution of osteoporotic females at different skeletal sites. Calcif Tissue Int 46:21–7CrossRefGoogle Scholar
  140. McCloskey EV, Spector TD, Eyres KS et al (1993) The assessment of vertebral deformity - a method for use in population studies and clinical trials. Osteoporosis Int 3:13–8CrossRefGoogle Scholar
  141. Meema HE, Oreopoulos DG (1983) The mode of Progression of subperiosteal resorption in the hyperparathyroidism of chronic renal failure. Skeletal Radiol 10:15–7CrossRefGoogle Scholar
  142. Meema HE, Oreopoulos DG, Murray TM (1986) Periosteal resorption and periosteal neostosis: comparison of normal subjects and renal failure patients on chronic ambulatory peritoneal dialysis using MOP-3 image analysis system and a grading method. Skeletal Radiol 15:1–4CrossRefGoogle Scholar
  143. Meema HE, Oreopoulos DG, Rabinovich S et al (1974) Periosteal new bone formation (periosteal neostosis) in renal osteodystrophy. Radiology 110:51–3Google Scholar
  144. Melton LJ, Eddy DM, Johnston CC (1990) Screening for Osteoporosis. Ann Inter Med 112:51–6CrossRefGoogle Scholar
  145. Meneghello A, Bertoli M (1984) Neuropathic arthropathy (Charcot's joint) in dialysis patients. RÖFO 141:18–0Google Scholar
  146. Meurs JBJ, Dhonukshe-Rutten RAM, Pluijm SMF et al (2004) Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 350:2–0CrossRefGoogle Scholar
  147. Miedlich S, Koch CA, Paschke R (2002) Primärer Hyperparathyreoidismus. Dtsch Ärztebl 99:C2620Google Scholar
  148. Minne HW (1989) Syndrome mit Hypokalzämie. In: Hesch RD Endokrinologie, Teil B. Urban und Schwarzenberg, München (Innere Medizin der Gegenwart Bd. 5, S 1214)Google Scholar
  149. Mithal A, Trivedi N, Gupta SK et al (1993) Radiological spectrum of endemic fluorosis: relationship with calcium intake. Skeletal Radiol 22:25–7CrossRefGoogle Scholar
  150. Mohr A, Barkmann R, Mohr C et al (2004) Quantitativer Ultraschall zur Osteoporosediagnostik. Röfo 176:61–0Google Scholar
  151. Montag M, Roos N, Peters PE (1989) Wirbelkörperläsionen als Störfaktor bei der quantitativen Computertomographie der Lendenwirbelsäule. RÖFO 151:31–7Google Scholar
  152. Mulliken BD, Renfrew DL, Brand RA et al (1994) Prevalence of previously undetected osteonecrosis of the femoral head in renal transplant recipients. Radiology 192:83–1CrossRefGoogle Scholar
  153. Munakata T, Nishida J, Shimamura T et al (1995) Simultaneous avulsion of patellar apexes bilaterally in a hemodialysis patient. Skeletal Radiol 24:21–1CrossRefGoogle Scholar
  154. Naidich JB, Mitchell IK, Mossey RT et al (1987) Osteoarthropathy of the hand and wrist in patients undergoing long-term hemodialysis. Radiology 164:20–5CrossRefGoogle Scholar
  155. Naidich JB, Mossey RT, McHeffey-Atkinson B et al (1988) Spondylarthropathy from long-term hemodialysis. Radiology 167:76–1CrossRefGoogle Scholar
  156. Nesbit M, Krivit W, Heyn R et al (1976) Acute and chronic effects of methotrexate on hepatic, pulmonary and skeletal systems. Cancer 37:104–8CrossRefGoogle Scholar
  157. Neumann E, Müller-Ladner U, Frommer KW (2014) Entzündung und Knochenmetabolismus. Z Rheumatol 73:34–2Google Scholar
  158. Nielsen SP, Slosman D, Sorensen DH et al (1999) Influence of strontium on bone mineral density and bone mineral content measurements by dual X-ray absorptiometry. J Clin Demitom 2:37–1Google Scholar
  159. Nordin BEC (1971) Clinical significance and pathogenesis of osteoporosis. Br Med J 1:57–1CrossRefGoogle Scholar
  160. Nuovo MA, Dorfmann HD, Sun CCJ et al (1989) Tumorinduced osteomalacia and rickets. Am J Surg Pathol 13:58–8Google Scholar
  161. Ogose A, Hotta I, Emura I et al (2001) Recurrant malignant variant of phosphaturic mesenchymal tumor with oncogenic osteomalacia. Skeletal Radiol 30:9–9CrossRefGoogle Scholar
  162. Pacifici R, Rupich R, Griffin M et al (1990) Dual energy radiography versus quantitative computertomography for the diagnosis of osteoporosis. J Clin Endocrinol Metab 70:70–5CrossRefGoogle Scholar
  163. Peh WCG, Reinus WR (1995) Lead arthropathy: a cause of delayed onset lead poisoning. Skeletal Radiol 24:35–7Google Scholar
  164. Pennes DR, Martel W, Ellis CN (1985) Retinoid-induced ossification of the posterior longitudinal ligament. Skeletal Radiol 14:19–1CrossRefGoogle Scholar
  165. Perry III HM, Weinstein RS, Teitelbaum SC et al (1982) Pseudofractures in the absence of osteomalacia. Skeletal Radiol 8:1–7CrossRefGoogle Scholar
  166. Persigehl M, Hövels-Gürich H, von Bernuth G (1984) Nebenwirkungen am Skelettsystem bei Behandlung mit Prostaglandin E. RÖFO 141:42–7Google Scholar
  167. Plotnikoff GA, Quigley JA (2003) Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 78:146–3CrossRefGoogle Scholar
  168. Poznanski AK, Fernbach SK, Berry TE (1985) Bone changes from prostaglandin therapy. Skeletal Radiol 14:2–0CrossRefGoogle Scholar
  169. Puig S, Felder-Puig (2006) Evidenzbasierte Radiologie: Ein neuer Ansatz zur Bewertung von klinisch angewandter radiologischer Diagnostik und Therapie. Fortschr Röntgenstr 178:67–1CrossRefGoogle Scholar
  170. Radford N, Church T, Speizer FF et al (2002) Risks of postmenopausal hormone replacement. JAMA 288:32–1Google Scholar
  171. Rauch M, Perez-Bouza A, Strunk A (2013) Braune Tumoren: Ein Fallstrick in der PET-CT-Diagnostik. Fortschr. Röntgenstr.185:77–0Google Scholar
  172. Raue F, Haag C, Rondot S et al (2006) Hereditäre Formen des primären Hyperparathyreoidismus. Osteologie 15:2–5CrossRefGoogle Scholar
  173. Raymakers JA, Hoekstra O, van Putten J et al (1986) Fracture prevalence and bone mineral mass in osteoporosis measured with computed tomography and dual energy photon absorptiometry. Skeletal Radiol 15:19–1CrossRefGoogle Scholar
  174. Raymakers JA, Kapelle JW, van Beresteijn ECH et al (1990) Assessment of osteoporotic spine deformity. Skeletal Radiol 19:9–1CrossRefGoogle Scholar
  175. Reid IR (2007) Bisphosphonates. Skeletal Radiol. 36:71–1CrossRefGoogle Scholar
  176. Reid IR, Brown JP, Burckhardt T et al (2002) Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med 346:65–3CrossRefGoogle Scholar
  177. Reid IR, Cundy T (2009) Osteonecrosis of the jaw. Skeletal Radiol 38:5PubMedCrossRefGoogle Scholar
  178. Renton P, Shaw DG (1976) Hypophosphatemic osteomalacia secondary to vascular tumors of bone and soft tissue. Skeletal Radiol 1:2–1CrossRefGoogle Scholar
  179. Resch H, Battmann A (1995) Die Bedeutung von Wachstumsfaktoren und Zytokinen im Knochenstoffwechsel und Remodeling. Osteologie 4:13–7Google Scholar
  180. Reuther G, Dören M, Peters PE (1994) Aussagefähigkeit und Interpretation der bildgebenden Osteodensitometrie am Beispiel der quantitativen CT. RÖFO 161:9–9Google Scholar
  181. Richardson ML, Pozzi-Mucelli RS, Kanter AS et al (1986) Bone mineral changes in primary hyperparathyroidism. Skeletal Radiol 15:8–5CrossRefGoogle Scholar
  182. Riggs BL, Hodgson St. F, Hoffman DL et al (1980) Treatment of primary osteoporosis with fluoride and calcium. Clinical tolerance and fracture occurrence. JAMA 243:44–6CrossRefGoogle Scholar
  183. Riggs Bl, Hodgson St. F, O’Fallon WM (1990) Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 322:80–2CrossRefGoogle Scholar
  184. Riggs BL, Wahner HJW, Dunn L et al (1981) Differential changes in bone mineral density of the appendicular and axial skeleton with aging. J Clin. Invest 67:32–8CrossRefGoogle Scholar
  185. Ringe JD (1991) Osteoporose. de Gruyter, BerlinGoogle Scholar
  186. Roholm K (1937) Fluoride intoxication. A clinical hygienic study with a review of the literature and some experimental investigations. Lewis, LondonGoogle Scholar
  187. Ross RK, Paganini-Hill A, Mack T et al (1981) Menopausal oestrogen therapy and protection from death from ischemic heart disease. Lancet I:858Google Scholar
  188. Ross PD, Davis JW, Vogel JM et al (1990) A critical review of bone mass and the risk of fractures in osteoporosis. Calcif Tissue Int 46:14–9CrossRefGoogle Scholar
  189. Rotand SG, Drueke TB (1999) Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 56:38–3CrossRefGoogle Scholar
  190. Rubin KR, Ballow M, Baron R et al (1988) Malignant osteoporosis and defective immunoregulation. Bone Miner Res 3:50–9Google Scholar
  191. Runeberg L, Miettinen TA, Nikkila EA (1972) Effect of cholestyramin on mineral excretion in man. Acta Med Scand 192:7–1Google Scholar
  192. Rutkowski R, Resnick P, McMaster JH (1979) Osteosarcoma occuring in osteogenesis imperfecta. J Bone Joint Surg (Am) 6:60–6Google Scholar
  193. Schadmand S, Klose KJ, Wandel E (1991) Dialyseassoziierte Amyloidosteopathie - radiologische Aspekte RÖFO 154:61–0Google Scholar
  194. Schneider T, Schneider R (2004) Behandlungsbedürftige Osteoporose oder physiologische Osteopenie? WHO-Definition im Gegensatz zum Utah Paradigma. Osteology 13:2–4Google Scholar
  195. Schulte BU, Brücker D, Trompeter M et al (2006) Ballonassistierte perkutane Vertebroplastie bei Patienten mit osteoporotischen Wirbelkörperkompressionsfrakturen - erste Ergebnisse. Fortschr Röntgenstr 178:20–7CrossRefGoogle Scholar
  196. Schulz EE, Flowers C, Sauser DD et al (1990) The causes of bone scintigram hot spots in fluoride-treated osteoporotic patients. J Bone Miner Res 5:20–1Google Scholar
  197. Schwartz AM, Leonidas JC (1984) Methotrexate osteopathy. Skeletal Radiol 11:1–3CrossRefGoogle Scholar
  198. Schwörer I, Kaul A, Stolpmann HJ et al (1983) Bleieinlagerung im Knochen - Röntgenaufnahme als Nachweismethode? RÖFO 138:8–4Google Scholar
  199. Sclafani SJ A, Vuletin JC, Tiversky J (1985) Lead arthropathy: arthritis caused by retained intraarticular bullets. Radiology 156:29–9CrossRefGoogle Scholar
  200. Seufert J, Ebert K, Müller J et al (2001) Octreotide therapy for tumor-induced osteomalacia. N Engl J Med 345:188–3CrossRefGoogle Scholar
  201. Shane E, Burr D, Abrahamsen B et al (2014) Atypical subtrochanteric and diaphyseal femoral fractures; second report of a task force of the American society for bone and mineral research. J Bone Miner Res. 29:1PubMedCrossRefGoogle Scholar
  202. Shane E, Burr D, Ebeling PR et al (2010) Atypical subtrochanteric and diaphyseal femoral fractures. Report of a task force of the American society for bone and mineral research. J.bone mineral Res. 25:226–7Google Scholar
  203. Sherrard DJ, Ott SM, Andress DL (1985) Pseudohyperparathyroidism: Syndrome associated with aluminium intoxication in patients with renal failure. Am J Med 79:12–7CrossRefGoogle Scholar
  204. Shimida H, Nakamura M, Morumo F (1983) Influence of aluminium on the effect of 1-Alpha (OH) D3 on renal osteodystrophy. Nephron 35:16–3Google Scholar
  205. Sillence D (1981) Osteogenesis imperfecta: an expanding panorama of variants. Clin Orthop 159:1–1Google Scholar
  206. Slavin RE, Swedo J, Cartwright J et al (1988) Lead arthritis and lead poisoning following bullet wounds: a clinicopathologic, ultrastructural, and microanalytic study of two cases. Hum Pathol 19:22–3CrossRefGoogle Scholar
  207. Solomons CC (1976) Osteogenesis imperfecta. Biochemical defects (Abstr.). Clin Orthop 116:25–9Google Scholar
  208. Spicher I-D, Keck E (1993) HLA-Phänotyp A2/B7 als Risikofaktor bei familiärer postmenopausaler Osteoporose. Osteologie 2:20–2Google Scholar
  209. Spitz J, Stoecker M, Clemenz N et al (1990) Vergleichende Messung des Knochenmineralgehaltes mit DPA und DPX - Erste klinische Erfahrungen. RÖFO 152:34–0Google Scholar
  210. Spriggs DW (1990) Osteoporosis pseudoglioma-syndrome. Skeletal Radiol 19:30–2CrossRefGoogle Scholar
  211. Squires JW, Pinch LW (1979) Heparin-induced spinal fractures. JAMA 241:241–7CrossRefGoogle Scholar
  212. Stäbler A, Kröner G, Seiderer M (1991) MRT der dialyseassoziierten, destruierenden Spondylarthropathie der Atlantoaxialregion. RÖFO 154:46–9Google Scholar
  213. Stanisaljevic S, Babcock A (1977) Fractures in children treated with methotrexate for leucaemia. Clin Orthop 125:1–3Google Scholar
  214. Sundaram M (1989) Renal osteodystrophy. Skeletal Radiol 18:41–5Google Scholar
  215. Sundaram M, Dessner D, Ballal S (1991) Solitary, spontaneous cervical and large bone fractures in aluminium osteodystrophy. Skeletal Radiol 20:9–1CrossRefGoogle Scholar
  216. Sundaram M, McCarthy EF (2000) Oncogenic osteomalacia. Skeletal Radiol 29:11–7Google Scholar
  217. Sundaram M, Philipps SR, Wolverson MK et al (1980) Ungual tufts in the follow up of patients on maintenance hemodialysis. Skeletal Radiol 5:24–7CrossRefGoogle Scholar
  218. Sundaram M, Wolverson MK (1982) The prevalence of skeletal surveys of patients on maintenance hemodialysis. Ann Intern Med 97:78–0CrossRefGoogle Scholar
  219. Sundaram M, Wolverson MK, Heiberg E et al (1981) Erosive azotemic osteodystrophy. AJR 136:36–3CrossRefGoogle Scholar
  220. Svedström E, Parto K, Marttinen M et al (1993) Skeletal manifestations of lysinuric proteinintolerance. Skeletal Radiol 22:1–1CrossRefGoogle Scholar
  221. Tamarozzi R, Bedani PL, Scutellari PN et al (1984) Periosteal new bone in uremic osteodystrophy. Skeletal Radiol 11:5–0CrossRefGoogle Scholar
  222. Templeton AW, Jaconett JR, Ormond RS (1962) Localized osteosclerosis in hyperparathyroidism. Radiology 78:95–5CrossRefGoogle Scholar
  223. Tins BJ, Cassar-Pullicino VN, Lalam R (2012) Venous air embolism in consecutive balloon kyphoplastie visualised on CT imaging. Skeletal Radiol 41:109–3CrossRefGoogle Scholar
  224. Tsuchiga K (1969) Causation of Ouch-ouch disease (ItaiItai Byo) - an introductory review; part I: nature of the disease; Keio J Med 18:18–1Google Scholar
  225. Van de Berg BC, Malghem, Goffin EJ et al (1994) Transient epiphyseal lesions in renal transplant recipients: presumed insufficiency stress fractures. Radiology 191:40–3CrossRefGoogle Scholar
  226. Van Holsbeeck M, Roex, Favril A et al (1987) Osteosclerosis in primary hyperparathyroidism. RÖFO 147:69–0Google Scholar
  227. Van Persijn van Meerten EL, Kroon HM, Papapoulos SE (1992) Epi- and metaphyseal changes in children caused by administration of bisphosphonates. Radiology 184:24–9Google Scholar
  228. Vieira RLV, Amaral D, Jesus-Garcia F et al (2006) Hyperplastic callus formation in osteogenesis imperfecta type V mimicking osteosarcoma: 4-year follow-up with resolution. Skeletal Radiol 35:40–2CrossRefGoogle Scholar
  229. Vigorita VJV, Silver JS, Eisemon EOE et al (2012) Osteoclast abnormalities in fractured bone during bisphosphonate treatment for osteoporosis: a case report. Skeletal Radiol 41:86–1CrossRefGoogle Scholar
  230. Vittali HP (1970) Knochenerkrankungen, Histologie und Klinik. Sandoz, NürnbergGoogle Scholar
  231. Ward AM, Udnoon S, Watkins J et al (1976) Immunological mechanisms in the pathogenesis of vinyl chloride disease. Br Med J 1:93–6Google Scholar
  232. Weidner N, Santa Cruz D (1987) Phosphaturic mesenchymal tumors. Cancer 59:144–2Google Scholar
  233. Weiske R, Munding M, Schneider HW (1988) Destruierende, nicht-infektiöse Spondyloarthropathie bei chronischer Niereninsuffizienz. RÖFO 149: 12–9Google Scholar
  234. Wells G, Tugwell P, Shea B et al (2002) Metanalysis of therapies for postmenopausal osteoporosis. Metaanalysis of the efficacy of hormone replacement therapy in preventing osteoporosis in postmenopausal women. Endrocr Rev 23:52–9CrossRefGoogle Scholar
  235. Whyte MP, Wenkert D, Clements KL et al (2003) Bisphosphonate-induced osteopetrosis. N Engl J Med 349:45–7CrossRefGoogle Scholar
  236. Wynn-Davies R, Gormley J (1981) Clinical and genetic patterns in osteogenesis imperfecta. Clin Orthop 159:2–6Google Scholar
  237. Young W, Sevcik M, Tallroth K (1991) Metaphyseal sclerosis in patients with chronic renal failure. Skeletal Radiol 20:19–7Google Scholar
  238. Zong-Cheng L, En-Huei W (1986) Osteoporosis - an early radiographic sign of endemic flurosis. Skeletal Radiol 15:35–0CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • J. Freyschmidt
    • 1
  1. 1.Klinikum Bremen-Mitte Beratungsstelle und ReferenzzentrumBremen

Personalised recommendations